Spondyloarthritis & psoriatic arthritis
World Café Report From the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 Annual Meeting and Trainee Symposium: Exploring GRAPPA’s Future Priorities
Study context
- Population
- Attendees of the GRAPPA 2024 annual meeting, Seattle, USA: rheumatologists, dermatologists, patient research partners, corporate partners, nonclinician scientists, advanced practice practitioners and trainees≈20 participants per room
- Outcome
- Specific areas of unmet need GRAPPA should prioritise in the forthcoming 5–10 years, and how
Methodological detailsWorld Café session, World Café format, 10 rooms, Each room had an assigned room leader, a moderator and a young GRAPPA member scribe
- World Café session
- World Café format
- 10 rooms
- Each room had an assigned room leader, a moderator and a young GRAPPA member scribe
Main finding
As reported in the abstract
Unmet needs for the next 5 to 10 years
- Most reported unmet need is research, followed by clinical, educational and administrative priorities
- Research to discover novel biomarkers
- Further research to address (and possibly predict) transition from psoriasis to PsA
- Multispecialty collaboration in clinical practice for management of comorbidities
- Cross-specialty education for greater understanding of PsD and its comorbidities
- Expansion of the reach and impact of GRAPPA's educational materials, recommendations and advocacy
Original publication
World Café Report From the GRAPPA 2024 Annual Meeting and Trainee Symposium: Exploring GRAPPA’s Future Priorities. J Rheumatol. Published 15 September 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →